Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice
The article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. Two novel risk charts (SCORE2 and SCORE2-OP) have been proposed that have undergone significant revision and require significant changes in primary care practice. It...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2022-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850030600707112960 |
|---|---|
| author | S. A. Shalnova |
| author_facet | S. A. Shalnova |
| author_sort | S. A. Shalnova |
| collection | DOAJ |
| description | The article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. Two novel risk charts (SCORE2 and SCORE2-OP) have been proposed that have undergone significant revision and require significant changes in primary care practice. It has been suggested that in modern conditions their practical introduction is premature, since the healthcare system is not ready for renewal. Therefore, time is needed to adapt it to the practical healthcare conditions and to revise the medical screening protocols, which will require financial costs. The implementation of these recommendations should be taken responsibly so as not to harm the existing system of preventive care. |
| format | Article |
| id | doaj-art-9e05d7ca5adf47ea948394ae6d485b8a |
| institution | DOAJ |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2022-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-9e05d7ca5adf47ea948394ae6d485b8a2025-08-20T02:59:11Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252022-01-0121110.15829/1728-8800-2022-31712438Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practiceS. A. Shalnova0National Medical Research Center for Therapy and Preventive MedicineThe article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. Two novel risk charts (SCORE2 and SCORE2-OP) have been proposed that have undergone significant revision and require significant changes in primary care practice. It has been suggested that in modern conditions their practical introduction is premature, since the healthcare system is not ready for renewal. Therefore, time is needed to adapt it to the practical healthcare conditions and to revise the medical screening protocols, which will require financial costs. The implementation of these recommendations should be taken responsibly so as not to harm the existing system of preventive care.https://cardiovascular.elpub.ru/jour/article/view/3171score 2score2-opnon-hdl cholesterolcardiovascular risk |
| spellingShingle | S. A. Shalnova Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice Кардиоваскулярная терапия и профилактика score 2 score2-op non-hdl cholesterol cardiovascular risk |
| title | Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
| title_full | Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
| title_fullStr | Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
| title_full_unstemmed | Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
| title_short | Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice |
| title_sort | comments on the section cardiovascular risk estimation in the 2021 european society of cardiology guidelines on cardiovascular disease prevention in clinical practice |
| topic | score 2 score2-op non-hdl cholesterol cardiovascular risk |
| url | https://cardiovascular.elpub.ru/jour/article/view/3171 |
| work_keys_str_mv | AT sashalnova commentsonthesectioncardiovascularriskestimationinthe2021europeansocietyofcardiologyguidelinesoncardiovasculardiseasepreventioninclinicalpractice |